Toggle light / dark theme

Harvard University and the Chinese University of Hong Kong researchers have developed a technique that increases the solubility of drug molecules by up to three orders of magnitude. This could be a breakthrough in drug formulation and delivery.

Over 60% of pharmaceutical drug candidates suffer from poor water solubility, which limits their bioavailability and therapeutic viability. Conventional techniques such as particle-size reduction, solid dispersion, lipid-based systems, and mesoporous confinement often have drug-specific limitations, can be costly to implement, and are prone to stability issues.

The newly developed approach addresses these issues by leveraging the competitive adsorption mechanism of drug molecules and water on engineered silica surfaces. It avoids chemical modification of drug molecules or using additional solubilizing agents to achieve solubility, potentially replacing multiple drug delivery technologies.

Researchers at the University of Houston’s Texas Center for Superconductivity have achieved another first in their quest toward ambient-pressure high-temperature superconductivity, bringing us one step closer to finding superconductors that work in everyday conditions—and potentially unlocking a new era of energy-efficient technologies.

In their study titled “Creation, stabilization, and investigation at of pressure-induced superconductivity in Bi0.5 Sb1.5 Te3,” published in the Proceedings of the National Academy of Sciences, professors Liangzi Deng and Paul Ching-Wu Chu of the UH Department of Physics set out to see if they could push Bi0.5 Sb1.5 Te3 (BST) into a under pressure—without altering its chemistry or structure.

“In 2001, scientists suspected that applying high pressure to BST changed its Fermi surface topology, leading to improved thermoelectric performance,” Deng said. “That connection between pressure, topology and superconductivity piqued our interest.”

Gardenias are known for their rich, earthy fragrance, waxy petals and brilliant white color that contrasts with the deep emerald green of their leaves. The plant has long been prized by herbalists, seekers of food and fabric dyes, and even pharmaceutical companies.

Now, a collaborative team of scientists at several research centers in the United States has found that a compound known as genipin, derived from the gardenia plant called Cape jasmine, can prompt nerve regeneration. Neurons damaged and stunted by disease find new life in the lab when exposed to the plant-derived compound.

The chemical comes from the fruit of this extraordinarily versatile plant. Gardenia shrubs, in general, are native to tropical and subtropical regions of Asia. But the plants are propagated globally by horticulturists and amateur gardeners who are most familiar with the flower’s beauty and the intoxicating scent of their perfume.

Make a tax-deductible donation of any amount to help support Closer To Truth continue making content like this: https://shorturl.at/OnyRq.

Can biology be explained entirely in terms of chemistry and then physics? If so, that’s “reductionism.” Or are there “emergent” properties at higher levels of the hierarchy of life that cannot be explained by properties at lower or more basic levels?

Alan C. Love, Ph.D., is a professor in the College of Liberal Arts at the University of Minnesota. He also serves as director of the Minnesota Center for Philosophy of Science.

Shop Closer To Truth merchandise for unique items like notebooks, mugs, and sweatshirts: https://bit.ly/3P2ogje.

Per-and polyfluoroalkyl substances (PFAS) are industrial chemicals used in the manufacturing of thousands of products, including cosmetics, carpeting, non-stick cookware, stain-resistant fabrics, firefighting foams, food packaging, and waterproof clothing.

They’re everywhere — the environment, our food, and even in our bodies. Peer-reviewed studies have shown that exposure to PFAS may lead to decreased fertility, developmental delays in children, and increased risk of some cancers. And they take hundreds or even thousands of years to break down.

For roughly the past 10 years, researchers have been looking for ways to remove PFAS from the environment or at least degrade them into harmless, inorganic compounds.

The automated synthesis of plasmonic nanoparticles with on-demand properties is a challenging task. Here the authors integrate a fluidic reactor, real-time characterization, and machine learning in a self-driven lab for the photochemical synthesis of nanoparticles with targeted properties.

The expression of genes has to be carefully regulated in cells; active genes give cells their identity and ability to function. Epigenetic features are just one way that cells control gene expression, and they do so without altering the sequence of genes. These may involve chemical groups like methyl tags that adorn DNA, or structural characteristics that relate to proteins that organize DNA. But scientists have also been learning about how epigenetics affect RNA. New findings on a balancing act in epigenetics, which works on DNA and RNA, have been reported in Cell.

When genes are expressed, they are transcribed into messenger RNA (mRNA) molecules. The cell can then translate those mRNA molecules into proteins, which carry out a variety of functions. Scientists have identified an epigenetic mechanism that seems to balance gene expression. One facet of the mechanism can promote the transcription and organization of genes, while the other causes mRNA transcripts to lose stability, and can adjust how those transcripts are used. This work has shown that DNA and RNA epigenetics may be more closely linked than known.

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D tissues with unprecedented speed, uniformity, and versatility. Using the technology, the team was able to richly label large tissue samples in a single day. In their new study in Nature Biotechnology, they also demonstrate that the ability to label proteins with antibodies at the single-cell level across large tissue samples can reveal insights left hidden by other widely used labeling methods.

Profiling the proteins that cells are making is a staple of studies in biology, neuroscience, and related fields because the proteins a cell is expressing at a given moment can reflect the functions the cell is trying to perform or its response to its circumstances, such as disease or treatment. As much as microscopy and labeling technologies have advanced, enabling innumerable discoveries, scientists have still lacked a reliable and practical way of tracking protein expression at the level of millions of densely packed individual cells in whole, 3D intact tissues. Often confined to thin tissue sections under slides, scientists therefore haven’t had tools to thoroughly appreciate cellular protein expression in the whole, connected systems in which it occurs.

“Conventionally, investigating the molecules within cells requires dissociating tissue into single cells or slicing it into thin sections, as light and chemicals required for analysis cannot penetrate deep into tissues. Our lab developed technologies such as CLARITY and SHIELD, which enable investigation of whole organs by rendering them transparent, but we now needed a way to chemically label whole organs to gain useful scientific insights,” says study senior author Kwanghun Chung, associate professor in The Picower Institute for Learning and Memory, the departments of Chemical Engineering and Brain and Cognitive Sciences, and the Institute for Medical Engineering and Science at MIT. “If cells within a tissue are not uniformly processed, they cannot be quantitatively compared. In conventional protein labeling, it can take weeks for these molecules to diffuse into intact organs, making uniform chemical processing of organ-scale tissues virtually impossible and extremely slow.”

Y ou could be forgiven for thinking that the turn of the millennium was a golden age for the life sciences. After the halcyon days of the 1950s and ’60s when the structure of DNA, the true nature of genes and the genetic code itself were discovered, the Human Genome Project, launched in 1990 and culminating with a preliminary announcement of the entire genome sequence in 2000, looked like – and was presented as – a comparably dramatic leap forward in our understanding of the basis of life itself. As Bill Clinton put it when the draft sequence was unveiled: ‘Today we are learning the language in which God created life.’ Portentous stuff.

The genome sequence reveals the order in which the chemical building blocks (of which there are four distinct types) that make up our DNA are arranged along the molecule’s double-helical strands. Our genomes each have around 3 billion of these ‘letters’; reading them all is a tremendous challenge, but the Human Genome Project (HGP) transformed genome sequencing within the space of a couple of decades from a very slow and expensive procedure into something you can get done by mail order for the price of a meal for two.

Since that first sequence was unveiled in 2000, hundreds of thousands of human genomes have now been decoded, giving an indication of the person-to-person variation in sequence. This information has provided a vital resource for biomedicine, enabling us, for example, to identify which parts of the genome correlate with which diseases and traits. And all that investment in gene-sequencing technology was more than justified merely by its use for studying and tracking the SARS-CoV-2 virus during the COVID-19 pandemic.